Literature DB >> 28983807

Relationship between tumor volume and quantitative values calculated using two-dimensional bone scan images.

Shota Hosokawa1,2, Kazumasa Inoue3, Yasuyuki Takahashi2, Kazunori Kawakami4, Daisuke Kano5,6, Yoshihiro Nakagami7,8, Masahiro Fukushi1.   

Abstract

The bone scan index (BSI) is calculated from a whole-body bone scan image; it shows the tumor burden in bone as a percentage of total skeletal mass. It has been used to determine the prognosis and to assess treatment effects; however, little has been reported on whether the BSI calculated using a two-dimensional image can accurately evaluate the three-dimensional spread in tumor volume. We investigated the relationship between tumor volume and BSI using Monte Carlo simulation (MCS). We simulated a gamma camera and constructed a voxel phantom based on an anthropomorphic phantom computed tomography (CT) image and gamma rays emitted from each part according to technetium-99m-labeled methylene diphosphonate (99mTc-MDP) uptake (bone 1, soft tissue 0.2, tumor 2-32). We constructed bone scan images from the obtained counts and analyzed them using the BSI calculation software. The BSI increased with increased tumor uptake (two- to 32-fold). However, there was not always a significant difference between change in BSI and tumor uptake of eight times or greater than that of bone. When BSI was calculated with a tumor having an uptake of four-to-eight times higher than that of bone, the BSI was consistent with tumor volume, but decreased to about half the tumor volume when tumors were in the thoracic spine (Th-spine) segment. The BSI can be a good indicator of tumor volume in most segments, even though it is affected by the tumor's 99mTc-MDP uptake. Nevertheless, values calculated from the Th-spine should be interpreted carefully.

Entities:  

Keywords:  Bone scan index; Bone scintigraphy; Computer-aided diagnosis; Geant4; Monte Carlo simulation

Mesh:

Substances:

Year:  2017        PMID: 28983807     DOI: 10.1007/s12194-017-0423-4

Source DB:  PubMed          Journal:  Radiol Phys Technol        ISSN: 1865-0333


  19 in total

1.  Analytic Validation of the Automated Bone Scan Index as an Imaging Biomarker to Standardize Quantitative Changes in Bone Scans of Patients with Metastatic Prostate Cancer.

Authors:  Aseem Anand; Michael J Morris; Reza Kaboteh; Lena Båth; May Sadik; Peter Gjertsson; Milan Lomsky; Lars Edenbrandt; David Minarik; Anders Bjartell
Journal:  J Nucl Med       Date:  2015-08-27       Impact factor: 10.057

2.  Trabecular bone density of male human cervical and lumbar vertebrae.

Authors:  Narayan Yoganandan; Frank A Pintar; Brian D Stemper; Jamie L Baisden; Recyi Aktay; Barry S Shender; Glenn Paskoff; Purushottam Laud
Journal:  Bone       Date:  2006-03-31       Impact factor: 4.398

3.  Stratification of patients with metastatic prostate cancer based on extent of disease on initial bone scan.

Authors:  M S Soloway; S W Hardeman; D Hickey; J Raymond; B Todd; S Soloway; M Moinuddin
Journal:  Cancer       Date:  1988-01-01       Impact factor: 6.860

4.  Whole body PET for the evaluation of bony metastases in patients with breast cancer: comparison with 99Tcm-MDP bone scintigraphy.

Authors:  M Ohta; Y Tokuda; Y Suzuki; M Kubota; H Makuuchi; T Tajima; S Nasu; Y Suzuki; S Yasuda; A Shohtsu
Journal:  Nucl Med Commun       Date:  2001-08       Impact factor: 1.690

5.  Pitfalls of FDG-PET for the diagnosis of osteoblastic bone metastases in patients with breast cancer.

Authors:  Takako Nakai; Chio Okuyama; Takao Kubota; Kei Yamada; Yo Ushijima; Keiko Taniike; Takako Suzuki; Tsunehiko Nishimura
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-08-20       Impact factor: 9.236

6.  SUV measurement of normal vertebrae using SPECT/CT with Tc-99m methylene diphosphonate.

Authors:  Tomohiro Kaneta; Matsuyoshi Ogawa; Hiromitsu Daisaki; Shintaro Nawata; Keisuke Yoshida; Tomio Inoue
Journal:  Am J Nucl Med Mol Imaging       Date:  2016-09-22

7.  A Preanalytic Validation Study of Automated Bone Scan Index: Effect on Accuracy and Reproducibility Due to the Procedural Variabilities in Bone Scan Image Acquisition.

Authors:  Aseem Anand; Michael J Morris; Reza Kaboteh; Mariana Reza; Elin Trägårdh; Naofumi Matsunaga; Lars Edenbrandt; Anders Bjartell; Steven M Larson; David Minarik
Journal:  J Nucl Med       Date:  2016-07-21       Impact factor: 10.057

8.  F-18 fluorodeoxyglucose positron-emission tomography in the diagnosis of tumor recurrence and metastases in the follow-up of patients with breast carcinoma: a comparison to conventional imaging.

Authors:  Hans-Jürgen Gallowitsch; Ewald Kresnik; Johann Gasser; Gerhild Kumnig; Isabel Igerc; Peter Mikosch; Peter Lind
Journal:  Invest Radiol       Date:  2003-05       Impact factor: 6.016

9.  A new parameter for measuring metastatic bone involvement by prostate cancer: the Bone Scan Index.

Authors:  M Imbriaco; S M Larson; H W Yeung; O R Mawlawi; Y Erdi; E S Venkatraman; H I Scher
Journal:  Clin Cancer Res       Date:  1998-07       Impact factor: 12.531

10.  Prognostic value of a computer-aided diagnosis system involving bone scans among men treated with docetaxel for metastatic castration-resistant prostate cancer.

Authors:  Koichi Uemura; Yasuhide Miyoshi; Takashi Kawahara; Shuko Yoneyama; Yusuke Hattori; Jun-ichi Teranishi; Keiichi Kondo; Masatoshi Moriyama; Shigeo Takebayashi; Yumiko Yokomizo; Masahiro Yao; Hiroji Uemura; Kazumi Noguchi
Journal:  BMC Cancer       Date:  2016-02-16       Impact factor: 4.430

View more
  1 in total

1.  Evaluation of bone metastatic burden by bone SPECT/CT in metastatic prostate cancer patients: defining threshold value for total bone uptake and assessment in radium-223 treated patients.

Authors:  Takuro Umeda; Mitsuru Koizumi; Shohei Fukai; Noriaki Miyaji; Kazuki Motegi; Shuto Nakazawa; Tomohiro Takiguchi
Journal:  Ann Nucl Med       Date:  2017-12-14       Impact factor: 2.668

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.